Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure

Yalta, KenanZorkun, Cafer2024-06-122024-06-1220180019-48322213-3763https://doi.org/10.1016/j.ihj.2017.11.003https://hdl.handle.net/20.500.14551/22097[Abstract Not Available]en10.1016/j.ihj.2017.11.003info:eu-repo/semantics/openAccessLeft Ventricular Reverse RemodellingSystolic Heart FailureSoluble ST2PrognosisSoluble ST2 biomarker and reverse remodelling in patients with systolic heart failureLetter701196196N/AWOS:0004875862000342-s2.0-8503356214729455780Q3